Mostly Markets
Subscribe
Stocks/Real Estate/Health Care REITs

VentasVTR

Health Care REITs · Chicago, Illinois · In the S&P 500
Solid businessPricier than peers
$84.80+1.30%After hours: $83.68 (−1.32%)At the close, 30 Oct · Prices from CNBC, may be delayed
▲ 21.5% over 1 year
Ventas over 1 yearDaily close, $, to 30 Oct 2026
$70$80$90$100Nov2026MarMayJulSep$84.80$80$100NovMarJul$84.80
Source: Nasdaq daily closes
Market value$44.84B
Price to earnings160.4x
Forward P/E108.3x
Dividend yield2.41%
Year to date+9.6%
One year+21.5%
Next earningsNot scheduled
SectorReal Estate
52-week range (closes)
$73.79$100.53

Quality and valuation

How Ventas compares with other real estate stocks. A description, not a recommendation.

Ventas and 7 health care reits peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: about averageValuation: pricier than most

An average business among real estate companies, priced above most of them.

Ventas trades at 108.3 times the next 12 months of expected earnings, against a median of 35.1x for the 30 real estate stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew faster than the sector median: +22.1% vs +5.5%
  • Keeps less of its revenue as profit (net margin): 4.0% vs 22.2%
VTR trades at 108.3x forward earnings, above the sector medianForward p/e, Health Care REITs peers
AMT27.8xSPG31.4xPSA33.0xPLD40.2xEQIX57.0xDLR76.9xWELL82.7xVTR108.3xSector median 35.1xAMT27.8xSPG31.4xPSA33.0xPLD40.2xEQIX57.0xDLR76.9xWELL82.7xVTR108.3xSector median 35.1x
Source: CNBC quotes; Mostly Markets

Financials

From Ventas's SEC filings, through the quarter ending 30 Sep 2026. Hover or tap a bar for its value.

Revenue grew 23.0% from a year earlierQuarterly revenue, $bn, latest Q3 ’26
$0.0bn$0.5bn$1.0bn$1.5bnQ4 ’24Q2 ’25Q4 ’25$1.8bnQ3 ’26$0bn$1bnQ4 ’24Q2 ’25Q4 ’25$1.8bnQ3 ’26
Source: SEC filings
Growth sped up to +23.0% last quarterRevenue growth, year on year, %
0%10%20%Q4 ’24Q2 ’25Q4 ’2523.0%Q3 ’260%10%20%Q4 ’24Q2 ’25Q4 ’2523.0%Q3 ’26
Source: SEC filings
Diluted EPS was $0.13 last quarterQuarterly diluted earnings per share, $
$0.00$0.05$0.10$0.15Q4 ’24Q2 ’25Q4 ’25$0.13Q3 ’26$0.00$0.05$0.10$0.15Q4 ’24Q2 ’25Q4 ’25$0.13Q3 ’26
Source: SEC filings
Last 12 monthsVTRSector median
Revenue growth+22.1%+5.5%
Price to earnings160.4x30.3x

Stories on Ventas

We haven't written about Ventas yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Health Care REITs, by market value.

CompanyPriceTodayYTDValue
WELLWelltower$234.60+0.61%+26.4%$172B
PLDPrologis$127.98−0.03%+0.3%$122B
EQIXEquinix$1,013.70−2.22%+32.3%$100B
AMTAmerican Tower$187.78+1.02%+7.0%$87.09B
SPGSimon Property Group$217.75+0.94%+17.6%$70.45B
DLRDigital Realty$180.70−1.21%+16.8%$67.04B
PSAPublic Storage$324.77+2.43%+25.2%$60.68B
ORealty Income$56.930.00%+1.0%$53.87B